NCT06658340Completed
Feasibility of a Well-being Promotion Self-management Intervention in Post-COVID-19 Patients
Positivity in Post-COVID: Promoting Well-being in Patients with Post-COVID-19 Syndrome - a Feasibility and Acceptability Study
Source: ClinicalTrials.gov · Last updated 28 Mar 2025
Brief summary (registry, in English)
A training comprised of positive psychological interventions set out to improve mental well-being was developed for post-COVID-19 patients. This study aims to evaluate the feasibility and acceptability of this training.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 34 (actual)
- First submitted
- 16 Oct 2024
- Start date
- 14 Jul 2024
- Primary completion date
- 14 Nov 2024
- Lead sponsor
- University of Twente
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT06658340
What you commit to
- Study type: Interventional
- Participants enrolled: 34
- From 14 Jul 2024 to the primary completion date, 14 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Recent (\<5 years) diagnosis of a mood disorder, anxiety disorder or other psychiatric condition
Who the study is looking for
- Strongly suspected or clinically confirmed post-COVID-19 syndrome, i.e. confirmed symptoms persisting for at least 3 months after strongly suspected or confirmed SARS-CoV-2 infection
- Ages ≥18 years
- Dutch proficiency
- Provided informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Twente Coordinator of this site? Confirm its status | Enschede | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.